Serina Therapeutics Inc (SER)
NYSEAMERICAN: SER · IEX Real-Time Price · USD
9.91
+0.20 (2.06%)
Jul 22, 2024, 10:06 AM EDT - Market open
Serina Therapeutics Employees
As of December 31, 2023, Serina Therapeutics had 11 total employees, including 9 full-time and 2 part-time employees.
Employees
11
Change
n/a
Growth
n/a
Revenue / Employee
$286,227
Profits / Employee
-$80,922
Market Cap
83.38M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 11 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Sangamo Therapeutics | 405 |
Protalix BioTherapeutics | 208 |
DBV Technologies | 105 |
Chimerix | 72 |
BioAtla | 65 |
PMV Pharmaceuticals | 63 |
AN2 Therapeutics | 41 |
SCYNEXIS | 29 |
SER News
- 3 days ago - Serina Therapeutics Appoints Srini Tenjarla, Ph.D. as Senior Vice President of CMC and Formulation - GlobeNewsWire
- 2 months ago - Serina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights - GlobeNewsWire
- 3 months ago - Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman - GlobeNewsWire
- 4 months ago - Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics - GlobeNewsWire
- 4 months ago - AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results - GlobeNewsWire
- 5 months ago - AGEX THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AgeX Therapeutics, Inc. - AGE - Business Wire
- 8 months ago - AgeX Therapeutics Reports Third Quarter 2023 Financial Results - Business Wire
- 11 months ago - Shareholder Alert: Ademi LLP investigates whether AgeX Therapeutics, Inc. has obtained a Fair Price in its transaction with Serina - PRNewsWire